Literature DB >> 26300672

Is it time to offer BRCA1 and BRCA2 testing to all Jewish women?

K A Metcalfe1, A Eisen2, J Lerner-Ellis3, S A Narod4.   

Abstract

Entities:  

Year:  2015        PMID： 26300672      PMCID： PMC4530819          DOI： 10.3747/co.22.2527

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  18 in total

1.  Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.

Authors:  Kelly Metcalfe; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; William D Foulkes; Charmaine Kim-Sing; Susan Neuhausen; Nadine Tung; Barry Rosen; Jacek Gronwald; Peter Ainsworth; Kevin Sweet; Andrea Eisen; Ping Sun; Steven A Narod
Journal:  J Natl Cancer Inst       Date:  2010-11-23       Impact factor: 13.506

2.  Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer.

Authors:  B Meiser; P Butow; M Friedlander; V Schnieden; M Gattas; J Kirk; G Suthers; E Haan; K Tucker
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

3.  Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.

Authors:  Brian S Finkelman; Wendy S Rubinstein; Sue Friedman; Tara M Friebel; Shera Dubitsky; Niecee Singer Schonberger; Rochelle Shoretz; Christian F Singer; Joanne L Blum; Nadine Tung; Olufunmilayo I Olopade; Jeffrey N Weitzel; Henry T Lynch; Carrie Snyder; Judy E Garber; Joellen Schildkraut; Mary B Daly; Claudine Isaacs; Gabrielle Pichert; Susan L Neuhausen; Fergus J Couch; Laura van't Veer; Rosalind Eeles; Elizabeth Bancroft; D Gareth Evans; Patricia A Ganz; Gail E Tomlinson; Steven A Narod; Ellen Matloff; Susan Domchek; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.

Authors:  Marc D Schwartz; Beth N Peshkin; Chanita Hughes; David Main; Claudine Isaacs; Caryn Lerman
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

6.  Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.

Authors:  K A Metcalfe; A Poll; M Llacuachaqui; S Nanda; A Tulman; N Mian; P Sun; S A Narod
Journal:  Clin Genet       Date:  2010-07-28       Impact factor: 4.438

7.  Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.

Authors:  Kelly A Metcalfe; Aletta Poll; Robert Royer; Marcia Llacuachaqui; Anna Tulman; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

8.  Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Authors:  Ranjit Manchanda; Rosa Legood; Matthew Burnell; Alistair McGuire; Maria Raikou; Kelly Loggenberg; Jane Wardle; Saskia Sanderson; Sue Gessler; Lucy Side; Nyala Balogun; Rakshit Desai; Ajith Kumar; Huw Dorkins; Yvonne Wallis; Cyril Chapman; Rohan Taylor; Chris Jacobs; Ian Tomlinson; Uziel Beller; Usha Menon; Ian Jacobs
Journal:  J Natl Cancer Inst       Date:  2014-11-30       Impact factor: 13.506

9.  Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.

Authors:  M Watson; C Foster; R Eeles; D Eccles; S Ashley; R Davidson; J Mackay; P J Morrison; P Hopwood; D G R Evans
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640

10.  A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing.

Authors:  K A Metcalfe; A Poll; R Royer; S Nanda; M Llacuachaqui; P Sun; S A Narod
Journal:  Br J Cancer       Date:  2013-06-18       Impact factor: 7.640
View more
  8 in total

1.  BRCA1/2 population screening: embracing the benefits.

Authors:  S E Plon
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

2.  BRCA testing in unaffected young women in the United States, 2006-2017.

Authors:  Fangjian Guo; Matthew Scholl; Erika L Fuchs; Abbey B Berenson; Yong-Fang Kuo
Journal:  Cancer       Date:  2019-09-30       Impact factor: 6.860

3.  Use of BRCA Mutation Test in the U.S., 2004-2014.

Authors:  Fangjian Guo; Jacqueline M Hirth; Yu-Li Lin; Gwyn Richardson; Lyuba Levine; Abbey B Berenson; Yong-Fang Kuo
Journal:  Am J Prev Med       Date:  2017-03-22       Impact factor: 5.043

4.  Community attitudes towards a Jewish community BRCA1/2 testing program.

Authors:  Nicole Cousens; Rajneesh Kaur; Bettina Meiser; Lesley Andrews
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

5.  A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.

Authors:  Ana F Best; Margaret A Tucker; Megan N Frone; Mark H Greene; June A Peters; Hormuzd A Katki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-28       Impact factor: 4.254

6.  Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.

Authors:  Debra T Linfield; Michael B Rothberg; Elizabeth R Pfoh; Ryan Noss; Lydia Cassard; Joseph C Powers; Laura Lipold; Kathryn A Martinez
Journal:  Breast Cancer Res Treat       Date:  2022-07-16       Impact factor: 4.624

7.  Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.

Authors:  Melanie W Hardy; Beth N Peshkin; Esther Rose; Mary Kathleen Ladd; Savannah Binion; Mara Tynan; Colleen M McBride; Karen A Grinzaid; Marc D Schwartz
Journal:  J Community Genet       Date:  2022-04-29

8.  Knowledge, Attitudes, Willingness to Pay, and Patient Preferences About Genetic Testing and Subsequent Risk Management for Cancer Prevention.

Authors:  Fangjian Guo; Jacqueline M Hirth; Erika L Fuchs; Leslie E Cofie; Veronica Brown; Yong-Fang Kuo; Maria E Fernandez; Abbey B Berenson
Journal:  J Cancer Educ       Date:  2022-04       Impact factor: 2.037
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.